There are some good people around this company The Ceo seems like a sincere guy. The board members are all investors. There seems to be a lot of belief in the bio technology. The stem cell application seems to be therapeutically conducive to helping numerous conditions including covid sufferers. Unlike many startups that have 3 years or less of treating human drama this company through reincarnation has amassed 14 years of historical data. This is no fly by night bio-tech company and a $26 million marketcap does not reflect a true and accurate value. Management is convinced they have something special. As a relatively new investor who has done considerable due diligence I cannot help but readily concur with their perspective.
https://www.youtube.com/watch?v=xAMC74YUxlU
Hemostemix (formerly Theravitae Inc.) commenced operations in 2006 as a clinical stage biotechnology company with a patented technology and ...